From Breakthroughs Blog: General

 
PATH, as secretariat of GHTC
Eight keys to success in building an effective coalition

We share our lessons learned in building a diverse, effective advocacy coalition for global health R&D.

Read More
PATH/Aaron Joel Santos
Celebrating over a decade of global health R&D advocacy

From humble origins to the premier advocacy organization focused on global health R&D. We tell the story of the birth of GHTC.

Read More
Research Roundup: cash prizes for R&D, genetically modified mosquitoes, and drones for rapid diagnosis

US Senator Bernie Sanders (I-VT) released a plan last week as part of his Democratic presidential bid to incentivize research and development (R&D) for new HIV/AIDS medicines while ensuring they remain affordable.

Read More
Research Roundup: antibiotic resistance in preemies, a low-cost TB test, and more

A new study out of the Washington University School of Medicine in St. Louis, Missouri, revealed a proliferation of antibiotic-resistant bacteria in the gastrointestinal tracts of premature infants.

Read More
Innovative health tools put the power of protection in women’s hands

This International Women’s Day, GHTC is celebrating two novel, female-initiated health technologies that have the potential to give women and girls greater control over their sexual and reproductive health, empowering them to make informed decisions about whether and when to have children and to protect themselves and their families from HIV and other sexually transmitted infections (STIs).

Read More
Research Roundup: A novel single-pill HIV treatment, a promising Ebola therapy, and a collaboration between Google and UNICEF to map Zika

Gilead Sciences, a California-based biopharmaceutical company, has received US Food and Drug Administration (FDA) approval for Odefsey®, a complete, single-pill regimen for HIV/AIDS.

Read More
Research Roundup: A vaginal ring to prevent HIV, antibodies against Ebola, and the US response to malaria

GHTC member the International Partnership for Microbicides (IPM) announced last week the results of two phase 3 clinical trials demonstrating that a monthly vaginal ring filled with the antiretroviral drug dapivirine can reduce the risk of HIV infection in women.

Read More
Research Roundup: Thermal blankets for preemies, remote critical care, and mechanisms to accelerate Zika R&D

Many of the 15 million babies born premature each year struggle with hypothermia and need help to stay warm.

Read More
Research Roundup: Drones to bolster supply chains, a mobile vaccine manufacturing kit, expanding access to new insecticides, and Zika vaccines

To bypass unreliable roads, a project funded by the Bill & Melinda Gates Foundation and the United Nations Population Fund is using drones to deliver contraceptives, condoms, and other health supplies to remote villages in sub-Saharan Africa.

Read More
Research Roundup: Zika edition

The US National Institutes of Health (NIH) is ramping up research for a vaccine against Zika, a mosquito-borne virus which is “spreading explosively” throughout the Americas and can cause birth defects, including microcephaly, which is associated with stunted head and brain development in newborns.

Read More
Setting the stage: UN High-Level Panel on Access to Medicines to consider IP, trade, human rights, and access to medicine

In November 2015, United Nations (UN) Secretary-General Ban Ki-moon convened a High-Level Panel on Access to Medicines to discuss and develop solutions to promote innovation and access to essential medicines, vaccines, diagnostics, and other health technologies needed to ensure health and well-being around the world.

Read More
Major R&D gaps exist for eight pathogens most likely to cause next epidemic

Last month, the World Health Organization (WHO) convened experts to determine which emerging diseases could become “the next Ebola”—those pathogens most likely to cause the next major epidemic.

Read More
WHO’s Doing What?

With the New Year underway, GHTC is looking forward to a busy spring of multilateral organization meetings—with a number of them impacting global health research and development (R&D). First on the agenda is the World Health Organization (WHO) Executive Board (EB) meeting on January 25–30 in Geneva, where the EB will receive updates on a number of topics and make important decisions, particularly around how to proceed with the next steps of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) process.

Read More
Harnessing health innovation to achieve the global goals

On January 1, the countdown to 2030 officially began with the implementation of the new global development goals.

Read More
Research Roundup: MERS vaccine for camels, lessons learned from Ebola R&D, and more

A new vaccine against Middle East Respiratory Syndrome (MERS) could save human lives by boosting immunity in camels. MERS, a virus that causes an innocuous cold in camels but kills nearly one-third of human patients, is primarily found in the Arabian Peninsula, where camels are common and 12 percent are infected at any given time.

Read More
PATH/Patrick McKern
Global Health Innovation Act has passed the House of Representatives

Last month, Representatives Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) introduced a new piece of legislation—the Global Health Innovation Act (H.R. 2241)—that would strengthen global health research and development (R&D) programming at the US Agency for International Development (USAID).

Read More
What we’re thankful for in global health

It’s that time of year when Americans chow down on turkey with family and friends and express gratitude for the many things in life for which they are most thankful.

Read More
PATH/Jennifer Fox
Germany announces second PDP funding round: What’s different and how does it impact global health R&D

Earlier this month, Germany’s Federal Ministry of Education and Research (BMBF) the renewal of the German funding program for product development partnerships (PDPs) conducting research and development (R&D) for health technologies to combat poverty-related and neglected diseases (PRNDs).

Read More
Tackling hidden hunger through innovation

When most people think of hunger, they think of a lack of food—a nation suffering from crop failure and famine, or a family that can’t afford to put enough food on the table.

Read More
New report on investment in R&D for HIV prevention highlights 2014 global funding trends

In this guest post, the HIV Vaccines & Microbicides Resource Tracking Working Group—comprised of AVAC as secretariat, the International AIDS Vaccine Initiative, and UNAIDS—discusses its new report examining investment in research and development (R&D) for HIV prevention options.

Read More
Architect of the Capitol
Celebrating America’s contributions to global health innovation

This Independence Day, GHTC is taking a break from our cookouts and parades to celebrate America’s extraordinary contributions to advancing innovation to save lives around the world.

Read More
New legislation would strengthen USAID’s role in global health R&D

Update: The Global Health Technologies Coalition is excited to announce that the Global Health Innovation Act (H.R. 2241) passed the House of Representatives on December 18.

Read More
PATH/Christopher Nelson
Research Roundup: Big Pharma’s role in antibiotic R&D, clinical trials for Ebola vaccines and drug-resistant tuberculosis treatments, and more

How can we get Big Pharma to invest in low-cost antibiotic research and development (R&D)?

Read More
PATH/Wendy Stone
Research Roundup: A promising malaria vaccine, a virulent new form of HIV, climate change, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Obama highlights global health and innovation in State of the Union address

While others were playing State of the Union bingo or creating pretty word clouds, GHTC was closely watching the State of the Union address to see what President Barack Obama would say about US engagement in global health and America’s leadership in science and innovation.

Read More
10 reasons why the US policymakers should support global health research and development

At the Global Health Technologies Coalition, our mission is to advance—through advocacy—the research and development (R&D) of new tools to prevent, diagnose, and treat global diseases.

Read More
Over 150 organizations and individuals urge UN to keep health R&D at the heart of the post-2015 agenda

With the 69th session of the United Nations (UN) General Assembly opening this week in New York and the global community debating how best to refine the post-2015 development agenda, over 150 organizations and individuals signed a petition to UN Secretary General Ban Ki-moon and Member States urging the UN to keep the research, development, and delivery of new and improved health tools at the heart of the post-2015 development agenda.

Read More
PATH/Eric Becker
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Addressing regulatory challenges through the product development process

In this guest post, Claire Wingfield—product development policy officer at PATH—writes about a new paper she developed for the GHTC that outlines key regulatory challenges encountered by nonprofit product developers.

PATH
Read More
The human face of global health R&D: Natalie Nelson and USAID

The US Agency for International Development (USAID) is the nation’s lead foreign assistance agency.

GHTC
Read More
The human face of global health R&D: Ted Prusik and USAID

The US Agency for International Development (USAID) is the nation’s lead foreign assistance agency.

GHTC
Read More
A big week for global health, innovation, and the post-2015 development agenda

This week, many GHTC members will be in New York for the sixty-eighth session of the United Nations’ General Assembly (UNGA), where, among other topics, progress toward meeting the Millennium Development Goals (MDGs) will be addressed.

GHTC
Read More
PATH/Gabe Bienczycki
Funding for global health R&D: good news and bad

Sometimes the best news is no news at all. That’s one of the thoughts that struck me while pondering the results of the latest G-FINDER survey on global funding of R&D for neglected diseases.

Policy Cures
Read More
CDC/ Prof. Woodbridge Foster; Prof. Frank H. Collins
Changing our definition of neglected diseases: Is it time to think beyond traditional terms?

Depending on who you ask, you’ll come up with a number of different definitions for what exactly characterizes a neglected disease, as there’s no generally accepted definition.

GHTC
Read More
PATH/Evelyn Hockstein
Celebrating the birthday of Breakthroughs: The best of the GHTC blog

It’s been a busy twelve months for the team at the Global Health Technologies Coalition!

GHTC
Read More